Logo image of CDLR

CADELER A/S-ADR (CDLR) Stock Fundamental Analysis

NYSE:CDLR - New York Stock Exchange, Inc. - US12738K1097 - ADR - Currency: USD

18.45  -0.08 (-0.43%)

After market: 18.45 0 (0%)

Fundamental Rating

4

Overall CDLR gets a fundamental rating of 4 out of 10. We evaluated CDLR against 47 industry peers in the Construction & Engineering industry. CDLR may be in some trouble as it scores bad on both profitability and health. CDLR is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CDLR has reported negative net income.
In multiple years CDLR reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CDLR reported negative operating cash flow in multiple years.
CDLR Yearly Net Income VS EBIT VS OCF VS FCFCDLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M

1.2 Ratios

CDLR's Return On Assets of -0.61% is on the low side compared to the rest of the industry. CDLR is outperformed by 68.09% of its industry peers.
The Return On Equity of CDLR (-0.98%) is worse than 65.96% of its industry peers.
Industry RankSector Rank
ROA -0.61%
ROE -0.98%
ROIC N/A
ROA(3y)2.66%
ROA(5y)-4.28%
ROE(3y)3.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CDLR Yearly ROA, ROE, ROICCDLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100 150

1.3 Margins

CDLR's Profit Margin has improved in the last couple of years.
CDLR's Operating Margin has improved in the last couple of years.
CDLR has a better Gross Margin (31.70%) than 85.11% of its industry peers.
In the last couple of years the Gross Margin of CDLR has grown nicely.
CDLR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.7%
OM growth 3YN/A
OM growth 5Y38.97%
PM growth 3YN/A
PM growth 5Y52.64%
GM growth 3YN/A
GM growth 5Y40.93%
CDLR Yearly Profit, Operating, Gross MarginsCDLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

CDLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CDLR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CDLR has more shares outstanding
CDLR has a better debt/assets ratio than last year.
CDLR Yearly Shares OutstandingCDLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CDLR Yearly Total Debt VS Total AssetsCDLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that CDLR is in the distress zone and has some risk of bankruptcy.
CDLR's Altman-Z score of 1.47 is on the low side compared to the rest of the industry. CDLR is outperformed by 68.09% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that CDLR is not too dependend on debt financing.
CDLR has a Debt to Equity ratio (0.49) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACCN/A
WACC6.53%
CDLR Yearly LT Debt VS Equity VS FCFCDLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.82 indicates that CDLR should not have too much problems paying its short term obligations.
The Current ratio of CDLR (1.82) is better than 85.11% of its industry peers.
A Quick Ratio of 1.81 indicates that CDLR should not have too much problems paying its short term obligations.
CDLR has a better Quick ratio (1.81) than 89.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.81
CDLR Yearly Current Assets VS Current LiabilitesCDLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

More info and screens

7

3. Growth

3.1 Past

CDLR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.91%.
Measured over the past years, CDLR shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.89% on average per year.
The Revenue has been growing slightly by 2.07% in the past year.
Measured over the past years, CDLR shows a quite strong growth in Revenue. The Revenue has been growing by 8.50% on average per year.
EPS 1Y (TTM)-73.91%
EPS 3YN/A
EPS 5Y47.89%
EPS Q2Q%N/A
Revenue 1Y (TTM)2.07%
Revenue growth 3Y77.26%
Revenue growth 5Y8.5%
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 134.68% on average over the next years. This is a very strong growth
CDLR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 73.31% yearly.
EPS Next Y214.64%
EPS Next 2Y223.81%
EPS Next 3Y182.33%
EPS Next 5Y134.68%
Revenue Next Year99.36%
Revenue Next 2Y100.34%
Revenue Next 3Y99.34%
Revenue Next 5Y73.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CDLR Yearly Revenue VS EstimatesCDLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CDLR Yearly EPS VS EstimatesCDLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CDLR. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 8.49, the valuation of CDLR can be described as reasonable.
Based on the Price/Forward Earnings ratio, CDLR is valued cheaper than 95.74% of the companies in the same industry.
CDLR is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 8.49
CDLR Price Earnings VS Forward Price EarningsCDLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

CDLR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CDLR is more expensive than 76.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 100.42
CDLR Per share dataCDLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

CDLR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CDLR's earnings are expected to grow with 182.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y223.81%
EPS Next 3Y182.33%

More info and screens

0

5. Dividend

5.1 Amount

CDLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CADELER A/S-ADR

NYSE:CDLR (3/7/2025, 8:11:16 PM)

After market: 18.45 0 (0%)

18.45

-0.08 (-0.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-26 2024-11-26/bmo
Earnings (Next)03-25 2025-03-25/amc
Inst Owners36.46%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.62B
Analysts86
Price Target21.69 (17.56%)
Short Float %1.04%
Short Ratio19.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.37%
Min EPS beat(2)-6.79%
Max EPS beat(2)31.53%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.64%
Min Revenue beat(2)-4.69%
Max Revenue beat(2)-4.58%
Revenue beat(4)2
Avg Revenue beat(4)24.65%
Min Revenue beat(4)-4.69%
Max Revenue beat(4)80.27%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.91%
PT rev (3m)-16.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28.14%
EPS NY rev (1m)0.49%
EPS NY rev (3m)19.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.38%
Revenue NY rev (1m)0.76%
Revenue NY rev (3m)4.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.49
P/S 6.69
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 1.34
EV/EBITDA 100.42
EPS(TTM)-0.3
EYN/A
EPS(NY)2.17
Fwd EY11.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.76
BVpS14.02
TBVpS13.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.61%
ROE -0.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.7%
FCFM N/A
ROA(3y)2.66%
ROA(5y)-4.28%
ROE(3y)3.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.73%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y38.97%
PM growth 3YN/A
PM growth 5Y52.64%
GM growth 3YN/A
GM growth 5Y40.93%
F-ScoreN/A
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 28.1
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.81
Altman-Z 1.47
F-ScoreN/A
WACC6.53%
ROIC/WACCN/A
Cap/Depr(3y)757.66%
Cap/Depr(5y)785.56%
Cap/Sales(3y)180.33%
Cap/Sales(5y)370.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.91%
EPS 3YN/A
EPS 5Y47.89%
EPS Q2Q%N/A
EPS Next Y214.64%
EPS Next 2Y223.81%
EPS Next 3Y182.33%
EPS Next 5Y134.68%
Revenue 1Y (TTM)2.07%
Revenue growth 3Y77.26%
Revenue growth 5Y8.5%
Sales Q2Q%N/A
Revenue Next Year99.36%
Revenue Next 2Y100.34%
Revenue Next 3Y99.34%
Revenue Next 5Y73.31%
EBIT growth 1Y-53.97%
EBIT growth 3YN/A
EBIT growth 5Y50.78%
EBIT Next Year429.35%
EBIT Next 3Y197.32%
EBIT Next 5Y142.74%
FCF growth 1Y98.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.28%
OCF growth 3YN/A
OCF growth 5Y39.15%